
Two new studies jointly published in Nature: The Clinical Microbiome reveal that certain species of fungi in the gut play a key role in the development of immune dysregulation and some pediatric allergic diseases — and may be promising targets for new therapies.

New research published in Cell Press by BC Children’s Hospital Research Institute (BCCHR) investigator Dr. Megan Levings and her team shows how using a standard approach to tracking immune cells is needed for both scientific research and the clinic.

The real message is that socioeconomic conditions shape what’s possible for families. That makes this a policy conversation.